Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease

NCT03992066 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia Associated With Chronic Kidney Disease

Interventions

DRUG: Vadadustat
DRUG: Darbepoetin alfa
DRUG: Epoetin alfa

Sponsor

Akebia Therapeutics